patients treated with imatinib mesylate prognostic factors for hematologic relapse of chronic phase CML Clonal evolution and lack of cytogenetic response are adverseMotomi Mori,Brian J. Druker,Michael E. O'Dwyer,Michael J. Mauro,Carolyn Blasdel,Melanie Farnsworth,Gwen Kurilikmsra(2010)引用 23|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要